Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
SELLAS Life Sciences Group, Inc.
Next earnings ≈ Jul 5, 2026 · est. from filing cadence
Last earnings -0.6% on 2026-05-12
Conservative balance sheet (liabilities/equity 0.11x); but revenue fell -100.0% YoY.
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
SELLAS Life Sciences Group, Inc. shows $0.00 in FY2023 revenue (-100.0% YoY), and -37.9% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
Sources: SEC EDGAR (CIK 0001390478, latest 10-Q filed 2026-05-12) · EODHD · rules-based read · as of 6/18/2026, 3:22:07 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $7.60M | $1.00M | $0.00 | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$25.3M | -$42.0M | -$37.9M | -$31.5M | -$28.3M |
| Net income | -$20.7M | -$41.3M | -$37.3M | -$30.9M | -$26.9M |
| Diluted EPS | -$1.34 | -$2.13 | -$1.34 | -$0.50 | -$0.25 |
| Net margin | -272.4% | -4130.1% | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
501 tracked peers · median
| 2026-01-07 | Varian John Director | Award | 50.0K | |
| 2026-01-07 | VAN NOSTRAND ROBERT L Director | Award | 50.0K | |
| 2026-01-07 | SCHEINBERG DAVID A Director | Award | 50.0K | |
| 2026-01-07 | CICIC DRAGAN SVP, Chief Development Officer | Award | 300K | |
| 2026-01-07 | Burns John Thomas CFO | Award | 300K | |
| 2026-01-07 | Kalin Katherine Bach Director | Award | 50.0K | |
| 2026-01-07 | Wasman Jane Director | Award | 50.0K | |
| 2025-12-03 | CICIC DRAGAN SVP, Chief Development Officer | Disposed (J) | 63.8K @ $1.50 | $95.7K |